Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blocking Glucose Metabolism Prevents Development of Metabolic Syndrome

By LabMedica International staff writers
Posted on 03 Sep 2018
A novel approach to preventing diabetes and other manifestations of metabolic syndrome, which includes obesity, diabetes, and fatty liver disease, showed promising results in mouse model systems.

The response by the liver to fasting has been proposed as a therapeutic pathway to enhance hepatic and whole-host metabolism. More...
However, the mechanisms underlying these metabolic effects remain unclear.

To help explain these mechanisms, investigators at Washington University School of Medicine (St. Louis, MO, USA) worked with various mouse models to evaluate the role of the enzyme epidermal-type lipoxygenase, eLOX3 (encoded by its gene, Aloxe3), as a potentially novel promotor of the therapeutic fasting response.

The investigators reported in the August 23, 2018, online edition of the journal JCI Insight that Aloxe3 was activated during fasting, glucose withdrawal, or trehalose/trehalose analogue treatment. Aloxe3 in the liver - whether activated by fasting or trehalose - improved the animals' insulin sensitivity as well as increasing calorie burning, raising body temperature, reducing weight gain and fat accumulation, and reducing levels of circulating fats and cholesterol in the blood.

In addition, administration of trehalose in the drinking water of mice fed an obesity-inducing diet protected the animals from developing metabolic disease. Although use of trehalose as a drug in humans is unlikely due to the ease in which it is broken down in the body, trehalose analogues such as lactotrehalose were found to demonstrate similar beneficial effects by activating Aloxe3 while not being as readily denatured.

"We learned that this gene, Aloxe3, improves insulin sensitivity in the same way that common diabetes drugs -- called thiazolidinediones -- improve insulin sensitivity," said senior author Dr. Brian DeBosch, assistant professor of pediatrics at Washington University School of Medicine. "And we showed that Aloxe3 activation in the liver is triggered by both trehalose and by fasting, possibly for the same reason: depriving the liver of glucose. In mice, this gene is turned on as part of what seems to be the normal fasting response. Our data suggest that fasting -- or giving trehalose with a normal diet -- triggers the liver to change the way it processes nutrients, in a beneficial way. And if glucose can be blocked from the liver with a drug, it may be possible to reap the benefits of fasting without strictly limiting food."

Related Links:
Washington University School of Medicine


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Serological Pipet Controller
PIPETBOY GENIUS
New
Laboratory Software
ArtelWare
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.